These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 23427955
1. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes. Boff B, Gaiddon C, Pfeffer M. Inorg Chem; 2013 Mar 04; 52(5):2705-15. PubMed ID: 23427955 [Abstract] [Full Text] [Related]
2. Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier. Fetzer L, Boff B, Ali M, Xiangjun M, Collin JP, Sirlin C, Gaiddon C, Pfeffer M. Dalton Trans; 2011 Sep 21; 40(35):8869-78. PubMed ID: 21837342 [Abstract] [Full Text] [Related]
3. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles. Büchel GE, Gavriluta A, Novak M, Meier SM, Jakupec MA, Cuzan O, Turta C, Tommasino JB, Jeanneau E, Novitchi G, Luneau D, Arion VB. Inorg Chem; 2013 Jun 03; 52(11):6273-85. PubMed ID: 23659478 [Abstract] [Full Text] [Related]
4. Arene ruthenium complexes as anticancer agents. Süss-Fink G. Dalton Trans; 2010 Feb 21; 39(7):1673-88. PubMed ID: 20449402 [Abstract] [Full Text] [Related]
5. Osmium(III) analogues of KP1019: electrochemical and chemical synthesis, spectroscopic characterization, X-ray crystallography, hydrolytic stability, and antiproliferative activity. Kuhn PS, Büchel GE, Jovanović KK, Filipović L, Radulović S, Rapta P, Arion VB. Inorg Chem; 2014 Oct 20; 53(20):11130-9. PubMed ID: 25290960 [Abstract] [Full Text] [Related]
6. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates. Riedl CA, Flocke LS, Hejl M, Roller A, Klose MH, Jakupec MA, Kandioller W, Keppler BK. Inorg Chem; 2017 Jan 03; 56(1):528-541. PubMed ID: 27996251 [Abstract] [Full Text] [Related]
7. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes. van Rijt SH, Hebden AJ, Amaresekera T, Deeth RJ, Clarkson GJ, Parsons S, McGowan PC, Sadler PJ. J Med Chem; 2009 Dec 10; 52(23):7753-64. PubMed ID: 19791745 [Abstract] [Full Text] [Related]
8. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications. Selvamurugan S, Ramachandran R, Viswanathamurthi P. Biometals; 2013 Oct 10; 26(5):741-53. PubMed ID: 23780567 [Abstract] [Full Text] [Related]
10. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity. Peacock AF, Parsons S, Sadler PJ. J Am Chem Soc; 2007 Mar 21; 129(11):3348-57. PubMed ID: 17319668 [Abstract] [Full Text] [Related]
11. A novel ruthenium(II) arene based intercalator with potent anticancer activity. Ruiz J, Vicente C, de Haro C, Bautista D. Dalton Trans; 2009 Jul 14; (26):5071-3. PubMed ID: 19562164 [Abstract] [Full Text] [Related]
12. High antitumor activity of 5,7-dihalo-8-quinolinolato tin(IV) complexes. Chen ZF, Peng Y, Gu YQ, Liu YC, Liu M, Huang KB, Hu K, Liang H. Eur J Med Chem; 2013 Apr 14; 62():51-8. PubMed ID: 23353732 [Abstract] [Full Text] [Related]
13. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents. Lucas SJ, Lord RM, Wilson RL, Phillips RM, Sridharan V, McGowan PC. Dalton Trans; 2012 Dec 07; 41(45):13800-2. PubMed ID: 23015068 [Abstract] [Full Text] [Related]
14. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. Peacock AF, Habtemariam A, Fernández R, Walland V, Fabbiani FP, Parsons S, Aird RE, Jodrell DI, Sadler PJ. J Am Chem Soc; 2006 Feb 08; 128(5):1739-48. PubMed ID: 16448150 [Abstract] [Full Text] [Related]
15. New titanocene derivatives with high antiproliferative activity against breast cancer cells. Saturnino C, Sirignano E, Botta A, Sinicropi MS, Caruso A, Pisano A, Lappano R, Maggiolini M, Longo P. Bioorg Med Chem Lett; 2014 Jan 01; 24(1):136-40. PubMed ID: 24332626 [Abstract] [Full Text] [Related]
16. 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity. Rocha FV, Barra CV, Netto AV, Mauro AE, Carlos IZ, Frem RC, Ananias SR, Quilles MB, Stevanato A, da Rocha MC. Eur J Med Chem; 2010 May 01; 45(5):1698-702. PubMed ID: 20116142 [Abstract] [Full Text] [Related]
17. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes. Pellei M, Gandin V, Marinelli M, Marzano C, Yousufuddin M, Dias HV, Santini C. Inorg Chem; 2012 Sep 17; 51(18):9873-82. PubMed ID: 22946642 [Abstract] [Full Text] [Related]
18. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand. Gao E, Liu L, Zhu M, Huang Y, Guan F, Gao X, Zhang M, Wang L, Zhang W, Sun Y. Inorg Chem; 2011 Jun 06; 50(11):4732-41. PubMed ID: 21520903 [Abstract] [Full Text] [Related]
19. Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death. Nazarov AA, Gardini D, Baquié M, Juillerat-Jeanneret L, Serkova TP, Shevtsova EP, Scopelliti R, Dyson PJ. Dalton Trans; 2013 Feb 21; 42(7):2347-50. PubMed ID: 23223548 [Abstract] [Full Text] [Related]
20. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity. Mulyana Y, Weber DK, Buck DP, Motti CA, Collins JG, Keene FR. Dalton Trans; 2011 Feb 21; 40(7):1510-23. PubMed ID: 21218244 [Abstract] [Full Text] [Related] Page: [Next] [New Search]